É. Long

发表

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method

T. Molina, P. Vielh, E. Selva, 2011, International journal of cancer.

LANA-1, Bcl-2, Mcl-1 and HIF-1α protein expression in HIV-associated Kaposi sarcoma

E. Selva, P. Hofman, G. Cathomas, 2009, Virchows Archiv.

EFA6B antagonizes breast cancer.

F. Bertucci, D. Birnbaum, B. Chetaille, 2014, Cancer research.

[Accreditation of the activity of molecular pathology according to ISO 15189: key steps to follow and the main potential pitfalls].

J. Sabourin, E. Selva, P. Hofman, 2013, Annales de pathologie.

Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls.

T. Molina, S. Lantuejoul, P. Bahadoran, 2011, American journal of clinical pathology.

Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients.

A. von Deimling, C. Marquette, D. Capper, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma

G. Poissonnet, A. Bozec, O. Dassonville, 2013, European Archives of Oto-Rhino-Laryngology.

Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France).

C. Marquette, S. Leroy, E. Selva, 2020, Biopreservation and biobanking.

MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib

N. Guevara, A. Bozec, J. Santini, 2016, Oncotarget.

Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France).

C. Marquette, F. Barlesi, J. Benzaquen, 2020, Lung cancer.

Intestinal occlusion caused by Rosai-Dorfman disease mimicking colonic diverticulitis.

P. Hofman, V. Hofman, S. Lassalle, 2007, Pathology, research and practice.

Primary clear cell meningioma of the orbit mimicking a metastatic carcinoma: usefulness of immunohistochemistry and cytogenetic analysis

G. Odin, P. Hofman, V. Hofman, 2008, Virchows Archiv.

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness

E. Gilson, P. Bahadoran, R. Ballotti, 2016, Cancer medicine.

Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France)

P. Laurent-Puig, P. Bahadoran, G. Poissonnet, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output.

A. Cambon-Thomsen, Georges Dagher, B. Parodi, 2013, Biopreservation and biobanking.

Aureobasidium pullulans contamination in bronchial aspirates mimicking cryptococcosis: a rare diagnostic pitfall.

P. Hofman, V. Hofman, É. Long, 2008, Pathology.

Identification of PPAP2B as a novel recurrent translocation partner gene of HMGA2 in lipomas

O. Myklebost, C. Dani, F. Pedeutour, 2013, Genes, chromosomes & cancer.

Identification of PPAP 2 B as a Novel Recurrent Translocation Partner Gene of HMGA 2 in Lipomas

O. Myklebost, C. Dani, F. Pedeutour, 2013 .

Usefulness of ancillary methods for diagnosis, prognosis and targeted therapy in thyroid pathology.

A. Bozec, J. Santini, P. Hofman, 2013, Current medicinal chemistry.

Molecular and Cellular Pathobiology EFA 6 B Antagonizes Breast Cancer

F. Bertucci, D. Birnbaum, B. Chetaille, 2014 .

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

C. Marquette, P. Hofman, V. Hofman, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer

H. Bégueret, X. Hébuterne, P. Hofman, 2014 .

KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives.

A. Didier, C. Marquette, J. Mazières, 2015, Current molecular medicine.

Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls.

C. Marquette, J. Mazières, G. Milano, 2014, Current molecular medicine.

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

C. Marquette, J. Benzaquen, P. Hofman, 2020, Cancers.

[Issues and current limits for immunohistochemical assessment of PD-L1 status in bronchial biopsies].

C. Marquette, J. Soria, P. Hofman, 2016, Bulletin du cancer.

Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

Marius Ilie, Paul Hofman, Elodie Long, 2014, Annals of translational medicine.

PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome

C. Marquette, E. Brambilla, P. Hofman, 2016, Modern Pathology.

Morphological analysis of circulating tumour cells in patients undergoing surgery for non‐small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method

T. Molina, J. Jais, C. Marquette, 2012, Cytopathology : official journal of the British Society for Clinical Cytology.

Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators.

E. Rakha, J. Lanchbury, M. Pajares, 2015, European journal of cancer.

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

C. Marquette, P. Hofman, V. Hofman, 2012 .

[Immunohistochemistry and personalised medicine in lung oncology: advantages and limitations].

P. Hofman, V. Hofman, S. Lassalle, 2014, Bulletin du cancer.

[Setting up a department of molecular pathology in oncology in a pathology laboratory (LPCE, CHU de Nice)].

C. Marquette, L. Castillo, J. Santini, 2013, Annales de pathologie.

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer

C. Marquette, E. Selva, P. Hofman, 2014, British Journal of Cancer.

Pericardial effusion as primary manifestation of metastatic cutaneous adenoid cystic carcinoma: Diagnostic cytopathology from an exfoliative sample

P. Hofman, M. Ilié, É. Long, 2008, Diagnostic cytopathology.

[Role of the surgical pathologist for tissue management in oncology].

P. Hofman, V. Hofman, S. Lassalle, 2013, Bulletin du Cancer.

Abstract 2220: PD-L1 expression in primary tumor and circulating tumor cells in patients with small cell lung carcinomas

C. Marquette, E. Selva, P. Hofman, 2016 .